1020 related articles for article (PubMed ID: 23079689)
1. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Kanis JA; McCloskey EV; Johansson H; Cooper C; Rizzoli R; Reginster JY;
Osteoporos Int; 2013 Jan; 24(1):23-57. PubMed ID: 23079689
[TBL] [Abstract][Full Text] [Related]
2. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Kanis JA; Cooper C; Rizzoli R; Reginster JY;
Osteoporos Int; 2019 Jan; 30(1):3-44. PubMed ID: 30324412
[TBL] [Abstract][Full Text] [Related]
3. Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Kanis JA; Cooper C; Rizzoli R; Reginster JY;
Aging Clin Exp Res; 2019 Jan; 31(1):15-17. PubMed ID: 30612282
[TBL] [Abstract][Full Text] [Related]
4. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
5. A comparison of case-finding strategies in the UK for the management of hip fractures.
Johansson H; Kanis JA; Oden A; Compston J; McCloskey E
Osteoporos Int; 2012 Mar; 23(3):907-15. PubMed ID: 22234810
[TBL] [Abstract][Full Text] [Related]
6. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.
Kanis JA; Harvey NC; McCloskey E; Bruyère O; Veronese N; Lorentzon M; Cooper C; Rizzoli R; Adib G; Al-Daghri N; Campusano C; Chandran M; Dawson-Hughes B; Javaid K; Jiwa F; Johansson H; Lee JK; Liu E; Messina D; Mkinsi O; Pinto D; Prieto-Alhambra D; Saag K; Xia W; Zakraoui L; Reginster J-
Osteoporos Int; 2020 Jan; 31(1):1-12. PubMed ID: 31720707
[TBL] [Abstract][Full Text] [Related]
7. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Kanis JA; Burlet N; Cooper C; Delmas PD; Reginster JY; Borgstrom F; Rizzoli R;
Osteoporos Int; 2008 Apr; 19(4):399-428. PubMed ID: 18266020
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study.
Roux C; Cooper C; Díez-Pérez A; Martinez L; Ortolani S; Gitlin M; Möller G; Shepherd S; Freemantle N
Osteoporos Int; 2011 Apr; 22(4):1227-36. PubMed ID: 20628731
[TBL] [Abstract][Full Text] [Related]
9. FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.
McCloskey E; Kanis JA; Johansson H; Harvey N; Odén A; Cooper A; Cooper C; Francis RM; Reid DM; Marsh D; Selby P; Thompson F; Hewitt S; Compston J
Osteoporos Int; 2015 Aug; 26(8):2091-9. PubMed ID: 26077380
[TBL] [Abstract][Full Text] [Related]
10. Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients.
Øyen J; Gjesdal CG; Brudvik C; Hove LM; Apalset EM; Gulseth HC; Haugeberg G
Osteoporos Int; 2010 Jul; 21(7):1257-67. PubMed ID: 19813045
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
Hernlund E; Svedbom A; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA
Arch Osteoporos; 2013; 8(1):136. PubMed ID: 24113837
[TBL] [Abstract][Full Text] [Related]
12. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.
McCloskey EV; Fitzpatrick LA; Hu MY; Williams G; Kanis JA
Arch Osteoporos; 2019 Feb; 14(1):15. PubMed ID: 30719589
[TBL] [Abstract][Full Text] [Related]
13. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.
Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
Osteoporos Int; 2010 Jan; 21(1):41-52. PubMed ID: 19705046
[TBL] [Abstract][Full Text] [Related]
14. Extensive undertreatment of osteoporosis in older Swedish women.
Lorentzon M; Nilsson AG; Johansson H; Kanis JA; Mellström D; Sundh D
Osteoporos Int; 2019 Jun; 30(6):1297-1305. PubMed ID: 30805678
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provinces.
Crilly RG; Kloseck M; Chesworth B; Mequanint S; Sadowski E; Gilliland J
Osteoporos Int; 2014 Jan; 25(1):205-10. PubMed ID: 23907572
[TBL] [Abstract][Full Text] [Related]
16. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
[TBL] [Abstract][Full Text] [Related]
17. Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Kanis JA; Cooper C; Rizzoli R; Reginster JY;
Calcif Tissue Int; 2019 Mar; 104(3):235-238. PubMed ID: 30796490
[TBL] [Abstract][Full Text] [Related]
18. Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women.
Cheung EY; Bow CH; Cheung CL; Soong C; Yeung S; Loong C; Kung A
Osteoporos Int; 2012 Mar; 23(3):871-8. PubMed ID: 21562875
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
Rubin KH; Rothmann MJ; Holmberg T; Høiberg M; Möller S; Barkmann R; Glüer CC; Hermann AP; Bech M; Gram J; Brixen K
Osteoporos Int; 2018 Mar; 29(3):567-578. PubMed ID: 29218381
[TBL] [Abstract][Full Text] [Related]
20. 2018 update of French recommendations on the management of postmenopausal osteoporosis.
Briot K; Roux C; Thomas T; Blain H; Buchon D; Chapurlat R; Debiais F; Feron JM; Gauvain JB; Guggenbuhl P; Legrand E; Lehr-Drylewicz AM; Lespessailles E; Tremollieres F; Weryha G; Cortet B
Joint Bone Spine; 2018 Oct; 85(5):519-530. PubMed ID: 29654947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
